Abbott Medical Devices
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Abbott Medical Devices sits in the top decile of US sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count).
Abbott Medical Devices: 261 sponsored US clinical trials, 23 recruiting.
Abbott Medical Devices sponsors 261 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 186 completed. 17 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Heart Failure, with 15 trials.
Top-decile sponsor footprint
Abbott Medical Devices ranks in the top decile of sponsors by registered trial count (#127 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
186 of 211 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
261 total, page 4 of 6
Trifecta™ Long Term Follow-Up (LTFU) Study
NCT01593917
Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study
NCT01485666
Driveline Silicone Skin Interface Registry
NCT01577433
Safety and Efficacy of the Accent Magnetic Resonance Imaging™ (MRI) Pacemaker and Tendril MRI™ Lead
NCT01576016
Quadripolar Pacing Post Approval Study
NCT01555619
Post-Approval Study Protocol of the St. Jude Medical Trifecta Valve
NCT01514162
Traumatic Brain Injury Peripheral Nerve Study
NCT01588691
Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
NCT01477528
Therapy™ Cool Flex™ Irrigated Ablation System for Typical Atrial Flutter
NCT01408485
Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device (LVAD) and Medical Management
NCT01452802
Absolute Pro® MOMENTUM™
NCT01444378
Atrial Flutter Ablation With Contact Therapy Cool Path Ablation System Along With EnSite Velocity Contact System
NCT01401361
Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy
NCT01445613
EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions
NCT01435031
ST Monitoring to Detect Acute Coronary Syndrome Events in Implantable Cardioverter Defibrillator Patients
NCT01424722
TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation
NCT01278953
XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study
NCT01249027
Angio-Seal Interventional Radiology (IR) Registry
NCT01222104
EXCEL Clinical Trial (Universal Registry)
NCT01205789
EXCEL Clinical Trial
NCT01205776
QuickFlex Micro Left Ventricular Lead Post Approval Study
NCT01179477
A Clinical Evaluation of the MINI TREK RX 1.20 mm Coronary Dilatation Catheter in Stenotic Lesions
NCT01186198
Real Time 3-Dimensional Echocardiography for Left Ventricular Lead Site Selection to Reduce Cardiac Resynchronization Therapy Non-Responder Rates
NCT01278030
FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMT
NCT01132495
Evaluate the Safety and Efficacy of OAS in Treating Severely Calcified Coronary Lesions
NCT01092416
AMPLATZER Cardiac Plug Clinical Trial
NCT01118299
Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
NCT01121107
Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
NCT00996086
Irrigated Ablation System Evaluation for Atrial Fibrillation (AF)
NCT01056328
Clinical Evaluation of Therapy™ Cool Path™ Duo Cardiac Ablation System for the Treatment of Typical Atrial Flutter (AFL)
NCT00984204
CentriMag RVAS U.S. Post-approval Study Protocol
NCT01568424
Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study
NCT00990665
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
NCT01106534
Comparison of the SUpera® PERipheral System in the Superficial Femoral Artery
NCT00933270
A Prospective Clinical Outcomes Registry
NCT01305525
SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients
NCT00940888
SPIRIT PRIME Clinical Trial
NCT00916370
Therapy Cool Path Ablate VT
NCT00925522
BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement
NCT00929474
Detect Fluid Early From Intra-thoracic Impedance Monitoring
NCT00916929
CONcomitant eValuation of Epicor Left atRial Therapy for AF
NCT00519194
OptiSense™ Performance in Detecting Atrial Episodes
NCT00870324
Trial to Evaluate the Safety & Efficacy of the Omnilink Elite™ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery
NCT01396525
Trial to Evaluate the Safety & Efficacy of the Absolute Pro™ Peripheral Self-Expanding Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery.
NCT00844532
Comparison of Fixed Tilt and Tuned Waveforms in Right-sided Implants
NCT00873691
Comparison of 50% Tilt and Tuned Waveforms in Single-Coil Active Can Configuration
NCT00874445
Real World Expanded Multicenter Study of the MitraClip® System (REALISM)
NCT01931956
Data Collection Study of Wedge Pressure Data in Patients With CRT-D Devices
NCT00811551
XIENCE V® EXCEED: Evaluation of XIENCE V® Catheterization Lab Endpoints and Excellence in Delivery
NCT00731237
Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead
NCT00763698
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 1 |
| Phase 3 | 11 |
| Phase 4 | 6 |
Therapeutic Areas
Where Abbott Medical Devices enrollment is open (later-stage tilt)
23 recruiting of 261 indexed (9% open); 186 completed (71%).
Phase mix: 17 late (III/IV) vs 5 early (I/II) (later-stage heavy).
Top condition: Heart Failure (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Abbott Medical Devices: open-pipeline peers nationwide
Peers matched on 261 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
Abbott Medical Devices sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 261 trials (± recruiting share)
- Pennington Biomedical Research Center · 258 trials · 13% recruiting
- Novartis · 265 trials · 0% recruiting
- University of Texas at Austin · 257 trials · 23% recruiting
- Boston Medical Center · 253 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Grifols Therapeutics · 9% recruiting · 34 trials
- Butler Hospital · 9% recruiting · 103 trials
- AMAG Pharmaceuticals · 9% recruiting · 23 trials
- Iowa State University · 9% recruiting · 23 trials
Related
What to do with this Abbott Medical Devices page
261 registered trials is a research-attention snapshot, not an endorsement of Abbott Medical Devices or any single study.
- 23 of Abbott Medical Devices's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Heart Failure is the condition Abbott Medical Devices studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Heart Failure trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Abbott Medical Devices pipeline card: 261 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.